RecruitingNCT07464821
National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
200 participants
Start Date
Feb 26, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
RASopathies, including Noonan syndrome, involve dysmorphisms, metabolic alterations, and an unfavorable lipid profile. This study investigates lipid and glucose metabolism to improve patient care.
Eligibility
Min Age: 2 YearsMax Age: 35 Years
Inclusion Criteria4
- Clinically diagnosed RASopathy confirmed by molecular testing;
- Patients referred to participating centers between 01/01/2001 and 31/12/2022;
- Age at enrollment between 2 and 35 years, inclusive;
- Obtaining informed consent.
Exclusion Criteria1
- None.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07464821
Related Trials
Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome
NCT052022101 location
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
NCT048889362 locations
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
NCT0666880524 locations
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
NCT053618111 location
Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
NCT073363941 location